Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
TempraMed Technologies Ltd. ( (TSE:VIVI) ) has shared an update.
TempraMed Technologies Ltd., a med‑tech firm focused on temperature-controlled devices for critical medications like insulin and GLP‑1, has built a portfolio around its VIVI platform, offering passive, space‑grade thermal protection through FDA-registered products that safeguard drug efficacy without external power. The company is now broadening its scope toward a whole‑patient digital health platform that merges physical device innovation with connected tools to support chronic disease management. In a strategic expansion of its product line, TempraMed has launched VIVI Cap Smart, a digitally enabled evolution of its VIVI Cap device that combines continuous, passive temperature protection with medication management features, including on-device injection timing display, a digital logbook via an optional mobile app, and data-sharing capabilities for healthcare providers. This launch adds a subscription-based, recurring-revenue element to TempraMed’s business model, creates new data and partnership opportunities with pharma and healthcare stakeholders, and positions the company to compete more directly in connected health by turning most insulin and GLP‑1 pens into temperature‑protected, connected devices aimed at improving treatment adherence and patient outcomes.
More about TempraMed Technologies Ltd.
TempraMed Technologies Ltd. is a medical-technology company specializing in temperature-controlled storage solutions for life‑saving medications, such as insulin and GLP‑1 therapies. Using patented, space‑grade, battery‑free thermal insulation technology, the company’s FDA-registered devices, including VIVI Cap and VIVI Epi, aim to protect medication integrity around the clock for patients and healthcare providers worldwide.
Average Trading Volume: 20,469
For a thorough assessment of VIVI stock, go to TipRanks’ Stock Analysis page.